TGF-β signaling in cancer metastasis
The DOI matches its Crossref record; 126 of the 126 references it cites were found in a registry or an index.
Abstract
The transforming growth factor (TGF)-β signaling events are well known to control diverse processes and numerous responses, such as cell proliferation, differentiation, apoptosis, and migration. TGF-β signaling plays context-dependent roles in cancer: in pre-malignant cells TGF-β primarily functions as a tumor suppressor, while in the later stages of cancer TGF-β signaling promotes invasion and metastasis. Recent studies have also suggested that the cross-talk between TGF-β signaling and other signaling pathways, such as Hippo, Wnt, EGFR/RAS, and PI3K/AKT pathways, may substantially contribute to our current understanding of TGF-β signaling and cancer. As a result of the wide-ranging effects of TGF-β, blockade of TGF-β and its downstream signaling components provides multiple therapeutic opportunities. Therefore, the outlook for anti-TGF-β signaling therapy for numerous diseases appears bright and will provide valuable information and thinking on the drug molecular design. In this review, we focus on recent insights into the regulation of TGF-β signaling in cancer metastasis which may contribute to the development of novel cancer-targeting therapies.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, cancer cells adapt to the protective TGF‐β signaling and utilize its moonlighting functions to create a conducive TME by activating CAFs, promoting angiogenesis and ECM production, and suppressing anti‐tumor immune responses [160, 161, 162].”
From Tumor microenvironment signaling and therapeutics in cancer progression (2023) · cites this paper as [162]
Citations
Cites
A ceRNA Hypothesis: The Rosetta Stone of a Hidden RNA Language?
Salmena, L., Poliseno, L., Tay, Y., Kats, L., & Pandolfi, P. P. (2011) · Cell · doi:10.1016/j.cell.2011.07.014 · Cited by 7,262
Long non-coding RNAs: insights into functions
Mercer, T. R., Dinger, M. E., & Mattick, J. S. (2009) · Nature Reviews Genetics · doi:10.1038/nrg2521 · Cited by 5,654 · cited 1×
“LncRNAs can regulate many important cancer-associated phenotypes, including proliferation, apoptosis, or cell migration, through their interactions with DNA, chromatin, signaling and regulatory proteins, and a variety of cellular RNA species [74,75].”
BackgroundSmad-dependent and Smad-independent pathways in TGF-β family signalling
Derynck, R., & Zhang, Y. E. (2003) · Nature · doi:10.1038/nature02006 · Cited by 5,373
Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis
Gupta, R. A., Shah, N., Wang, K. C., Kim, J., Horlings, H. M., Wong, D. J., Tsai, M.-C., Hung, T., Argani, P., Rinn, J. L., et al. (2010) · Nature · doi:10.1038/nature08975 · Cited by 5,218 · cited 1×
“The HOX-associated lncRNA HOTAIR can reprogram the chromatin landscape genomewide via recruitment of polycomb repressive complex 2 (PRC2), leading to increased breast cancer invasiveness and metastasis [87].”
BackgroundTumour exosome integrins determine organotropic metastasis
Hoshino, A., Costa-Silva, B., Shen, T.-L., Rodrigues, G., Hashimoto, A., Tesic Mark, M., Molina, H., Kohsaka, S., Di Giannatale, A., Ceder, S., et al. (2015) · Nature · doi:10.1038/nature15756 · Cited by 5,101 · cited 1×
“Certain tumors produce metastasis to specific organs independent of vascular anatomy, rate of blood flow, and the number of tumor cells delivered to each organ, and this organotropic metastasis depends on the extracellular vesicles such as exosomal integrins α6β4 and α6β1 [62].”
BackgroundEvolution and Functions of Long Noncoding RNAs
Ponting, C. P., Oliver, P. L., & Reik, W. (2009) · Cell · doi:10.1016/j.cell.2009.02.006 · Cited by 4,208 · cited 1×
“LncRNAs can regulate many important cancer-associated phenotypes, including proliferation, apoptosis, or cell migration, through their interactions with DNA, chromatin, signaling and regulatory proteins, and a variety of cellular RNA species [74,75].”
BackgroundTumor Metastasis: Molecular Insights and Evolving Paradigms
Valastyan, S., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.09.024 · Cited by 4,011
Gregory, P. A., Bert, A. G., Paterson, E. L., Barry, S. C., Tsykin, A., Farshid, G., Vadas, M. A., Khew-Goodall, Y., & Goodall, G. J. (2008) · Nature Cell Biology · doi:10.1038/ncb1722 · Cited by 3,863 · cited 1×
“The miR-200 family has been identified to repress EMT and tumor invasion by targeting the 3′ UTRs of the zinc-finger E-box binding factors 1 and 2 (ZEB1/2) [84,85].”
BackgroundMassagué, J. (2012) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3434 · Cited by 3,128
Long non-coding RNAs: new players in cell differentiation and development
Fatica, A., & Bozzoni, I. (2014) · Nature Reviews Genetics · doi:10.1038/nrg3606 · Cited by 2,980 · cited 1×
“LncRNA BRAF (V600E) regulates melanoma cell migration and lncRNA GAPLINC regulates CD44dependent cell invasiveness [78,79].”
Background
Cited by
Items 101–200 of 256
Xu, J., Ma, L., Wang, D., & Yang, J. (2022) · BMC Molecular and Cell Biology · doi:10.1186/s12860-022-00416-7 · Cited by 21
“The receptor complex is activated, and TGF-β signaling is ultimately initiated through the specific C-terminal phosphorylation of SMADs (R-SMADs), SMAD2 and SMAD3 [11].”
BackgroundHu, P., Liang, Y., Hu, Q., Wang, H., Cai, Z., He, J., Cai, J., Liu, M., Qin, Y., Yu, X., et al. (2018) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmy110 · Cited by 21
Gao, S., Zhang, Z., Wang, X., Ma, Y., Li, C., Liu, H., Jing, C., Li, L., & Guo, X. (2022) · Journal of Translational Medicine · doi:10.1186/s12967-022-03253-6 · Cited by 20
Dong, Y., Ding, D., Gu, J., Chen, M., & Li, S. (2022) · Bioengineered · doi:10.1080/21655979.2022.2081465 · Cited by 20
“RAS are stimulated to promote cancer development [28].”
RetractedKisling, S. G., Natarajan, G., Pothuraju, R., Shah, A., Batra, S. K., & Kaur, S. (2021) · Cancer and Metastasis Reviews · doi:10.1007/s10555-021-09991-1 · Cited by 20
Li, H., Wang, S., Li, X., Weng, Y., Guo, D., Kong, P., Cheng, C., Wang, Y., Zhang, L., Cheng, X., et al. (2022) · Cancer Science · doi:10.1111/cas.15560 · Cited by 20
Self-citationZhang, X., Wang, G., Gong, Y., Zhao, L., Song, P., Zhang, H., Zhang, Y., Ju, H., Wang, X., Wang, B., et al. (2023) · iScience · doi:10.1016/j.isci.2023.106639 · Cited by 20
“1 ll OPEN ACCESS that promotes invasion, angiogenesis as well as suppression of the immune system.20 Recent studies have suggested that TGF-b can also induce sustained EGFR transactivation in rat mesangial cells through nonligand-dependent pathways.21 During cancer metastasis, the TGF-b pathway and other signaling cas…”
BackgroundMicroRNAs: A novel signature in the metastasis of esophageal squamous cell carcinoma
Wei, Q.-Y., Jin, F., Wang, Z., Li, B., Cao, W., Sun, Z., & Mo, S. (2024) · World Journal of Gastroenterology · doi:10.3748/wjg.v30.i11.1497 · Cited by 19
Structure, unique biological properties, and mechanisms of action of transforming growth factor β
Zelisko, N., Lesyk, R., & Стойка, Р. С. (2024) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2024.107611 · Cited by 19
Manipulating TGF-β signaling to optimize immunotherapy for cervical cancer
Yin, S., Cui, H., Qin, S., & Yu, S. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115355 · Cited by 19
Grgurević, L., Novak, R., Trkulja, V., Hrkač, S., Salai, G., Bilandžić, J., Hamzić, L. F., Milas, I., Vučemilo, T., Balja, M. P., et al. (2020) · Journal of Translational Medicine · doi:10.1186/s12967-020-02659-4 · Cited by 18
Poleboyina, P. K., Naik, U., Pasha, A., Ravinder, D., Bhanothu, S., Poleboyina, S. M., Amineni, U. M., & Pawar, S. C. (2023) · Applied Biochemistry and Biotechnology · doi:10.1007/s12010-023-04608-5 · Cited by 18
Li, H., Li, S., Luo, Y., Xu, W., Zhang, Y., Zhang, T., Zhang, D., & Jin, C. (2020) · Natural Product Communications · doi:10.1177/1934578x20935226 · Cited by 18
Antitumor Effects of Baicalein and Its Mechanism via TGFβ Pathway in Cervical Cancer HeLa Cells
Yu, G., Chen, L., Hu, Y., Yuan, Z., Luo, Y., & Xiong, Y. (2021) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2021/5527190 · Cited by 17
Machado, C. B., da Cunha, L. S., Maués, J. H. D. S., Pessoa, F. M. C. D. P., de Oliveira, M. B., Ribeiro, R. M., Lopes, G. S., de Moraes, M. O., de Moraes, M. E. A., Khayat, A. S., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23105486 · Cited by 17
Jayathirtha, M., Neagu, A.-N., Whitham, D., Alwine, S., & Darie, C. C. (2022) · PubMed · Cited by 17
Liver Microenvironment Response to Prostate Cancer Metastasis and Hormonal Therapy
Buxton, A. K., Abbasova, S., Bevan, C. L., & Leach, D. A. (2022) · Cancers · doi:10.3390/cancers14246189 · Cited by 17
“Importantly, TGF-ß is integral to fibrotic responses, and is also known to be increased in PCa liver metastases [51,115], and to promote invasion and metastasis, all potential reasons why cancer cells metastasize to and grow in the liver [116].”
BackgroundJin, M., Gao, D., Wang, R., Attila Gabor, S. I. K., & Liu, K. (2020) · Oncology Reports · doi:10.3892/or.2020.7644 · Cited by 16
Zhang, G., Chen, W.-Y., Li, X., Ke, H., & Zhou, X.-L. (2021) · Open Life Sciences · doi:10.1515/biol-2021-0085 · Cited by 16
“TGF-β exerts tumor-suppressive functions primarily resulting in apoptosis in the early phase of tumorigenesis [23].”
BackgroundRoles of TGF‑β signalling pathway‑related lncRNAs in cancer (Review)
Hu, Z., Liu, Y., Liu, M., Zhang, Y., & Wang, C. (2023) · Oncology Letters · doi:10.3892/ol.2023.13693 · Cited by 16
MIR503HG: A potential diagnostic and therapeutic target in human diseases
Han, X., Li, B., & Zhang, S. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114314 · Cited by 16
Dextran Sulfate Effects EMT of Human Gastric Cancer Cells by Reducing HIF-1α/ TGF-β
Huang, Y., Xu, Y.-Y., Ma, Q., Li, M.-Q., Guo, J., Wang, X., Jin, X., Shang, J., & Jiao, L.-X. (2021) · Journal of Cancer · doi:10.7150/jca.55550 · Cited by 16
Unlocking the dual role of LSD1 in tumor immunity: innate and adaptive pathways
Zhang, Y. L., Guo, N., Zhu, H., Liu, M., Hao, J., Wang, S., Guo, T., Mamun, M., Pang, J., Liu, Q., et al. (2024) · Theranostics · doi:10.7150/thno.102037 · Cited by 15
Menck, K., Wlochowitz, D., Wachter, A., Conradi, L., Wolff, A., Scheel, A. H., Korf, U., Wiemann, S., Schildhaus, H., Bohnenberger, H., et al. (2022) · Cancers · doi:10.3390/cancers14092084 · Cited by 15
Cruz, E. M. S., Concato, V. M., Valentim, J. M. B. D. M., Silva, T. F., Inoue, F. S. R., de Souza, M. C., Bidóia, D. L., Machado, R. R. B., Chuffa, L. G. D. A., Mantovani, M. S., et al. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.121530 · Cited by 15
Hao, F., Zhu, Q., Lu, L., Sun, S., Huang, Y., Zhang, J., Liu, Z., Miao, Y., Jiao, X., & Chen, D. (2020) · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · doi:10.3727/096504020x15834065061807 · Cited by 15
Li, Q., Ma, Y., Liu, X., Li, M., He, B., Wu, K., & Sun, W. (2020) · Oncology Reports · doi:10.3892/or.2020.7745 · Cited by 15
Jiang, Y., Li, X., Tan, Y., Fang, Y., Liu, K.-Y., Wang, Y.-F., Ma, T., Ou, Q.-J., & Zhang, C. (2024) · Food & Function · doi:10.1039/d4fo02346c · Cited by 14
Fang, C., Zhang, X., Li, C., Liu, F., & Liu, H. (2021) · Digestive Diseases and Sciences · doi:10.1007/s10620-021-07287-6 · Cited by 14
“TGF-β pathway plays a pivotal influence in diverse processes of cell proliferation, migration, differentiation, and apoptosis [29].”
BackgroundConstruction of a four-mRNA prognostic signature with its ceRNA network in CESC
Li, L., Guo, Q., Lan, G., Liu, F., Wang, W., & Lv, X. (2022) · Scientific Reports · doi:10.1038/s41598-022-14732-7 · Cited by 14
Du, L., Li, J., Tian, Y., & Feng, R. (2023) · Cancer Science · doi:10.1111/cas.15791 · Cited by 14
Khabipov, A., Freund, E., Liedtke, K. R., Käding, A., Riese, J., van der Linde, J., Kersting, S., Partecke, L.-I., & Bekeschus, S. (2021) · Cancers · doi:10.3390/cancers13112525 · Cited by 14
“In cancer stages of manifested tumors, TGFβ increases the risk of metastasis [39,40].”
BackgroundChen, C., Huang, R., Zhou, J., Guo, L., & Xiang, S. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.897942 · Cited by 14
Guo, X., Zhou, H., Liu, Y., Xu, W., Kanwore, K., & Zhang, L. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms251810229 · Cited by 13
Self-citationValproic Acid Inhibits Glioma and Its Mechanisms
Yang, Z., & Wang, X.-H. (2022) · Journal of Healthcare Engineering · doi:10.1155/2022/4985781 · Cited by 13
“Studies have focused on the important role of TGF-β in different stages of tumorigenesis and EMT, but its role in the initial response to EMTremains unclear [4, 5].”
BackgroundReceptor-Mediated Redox Imbalance: An Emerging Clinical Avenue against Aggressive Cancers
Dai, X., Thompson, E. W., & Ostrikov, K. (2022) · Biomolecules · doi:10.3390/biom12121880 · Cited by 13
“On ligand binding, TGFβR dimerizes to induce serine/threonine phosphorylation followed by the phosphorylation of its intracellular effectors SMADs (referred to as canonical TGFβ/SMAD signaling) or critical intermediates involved in other pathways such as PI3K/AKT/mTOR, MAPK, and Rho-like GTPase signaling (known as TGF…”
BackgroundGe, Z., Wu, S., Qi, Z., & Ding, S. (2022) · Journal of Cancer · doi:10.7150/jca.66245 · Cited by 13
“In healthy cells and pre-malignant cells, TGF-β1 primarily functions as a tumor suppressor, while in the later stage of cancer, TGF-β1 signaling promotes tumor invasion and metastasis [15].”
BackgroundComprehensive analysis of INHBA: A biomarker for anti-TGFβ treatment in head and neck cancer
Zhang, S., Jin, K., Li, T., Zhou, M., & Yang, W. (2022) · Experimental Biology and Medicine · doi:10.1177/15353702221085203 · Cited by 13
Yavuz, M., Takanlou, L. S., Avcı, Ç. B., & Demircan, T. (2023) · Gene · doi:10.1016/j.gene.2023.147390 · Cited by 12
Zhou, Z., Wu, B. Y., Chen, J., Shen, Y., Wang, J., Chen, X., Fei, F., & Li, L. (2023) · Genes & Genomics · doi:10.1007/s13258-023-01428-z · Cited by 12
“In addition, this study observed that B3GNT3 participated in regulating the TGF-β signaling pathway that takes a critical part in controlling cell proliferation, differentiation, apoptosis, migration, and invasion (Xie et al. 2018; Zhao et al. 2018).”
BackgroundXie, W., Xiao, H., Luo, J., Zhao, L., Jin, F., Ma, J., Li, J., Xiong, K., Chen, C., & Wang, G. (2020) · Current Problems in Cancer · doi:10.1016/j.currproblcancer.2020.100593 · Cited by 12
Gundlach, J.-P., Hauser, C., Schlegel, F. M., Willms, A., Halske, C., Röder, C., Krüger, S., Röcken, C., Becker, T., Kalthoff, H., et al. (2021) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-021-03745-w · Cited by 12
Ni‐induced TGF‐β signaling promotes VEGF‐a secretion via integrin β3 upregulation
Wu, C., Ko, J., Pan, H., Chiu, L., Kang, Y., & Hsiao, Y. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.28772 · Cited by 12
The Role of Cell Division Autoantigen 1 (CDA1) in Renal Fibrosis of Diabetic Nephropathy
Chen, L., Wu, J., Hu, B., Liu, C.-B., & Wang, H. (2021) · BioMed Research International · doi:10.1155/2021/6651075 · Cited by 12
“But TGF-β1, a member of the TGF-β superfamily, is a pleiotropic cytokine with a wide variety of physiological roles that include not only regulating tissue fibrosis but also regulating many biological responses, including wound healing [23], cell proliferation, cell differentiation, ECM production and remodeling, chem…”
BackgroundOlivares, A., Alcaraz-Saura, M., Achel, D. G., Berná-Mestre, J. D. D., & Alcaraz, M. (2021) · Antioxidants · doi:10.3390/antiox10020231 · Cited by 11
Abedi, S., Behmanesh, A., Mazhar, F. N., Bagherifard, A., Sami, S. H., Heidari, N., Hossein‐Khannazer, N., Namazifard, S., Arki, M. K., Shams, R., et al. (2024) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2024.167357 · Cited by 10
Wang, N., Liu, X., Fang, X., Chen, S., Xi, Z., Zhang, X., Xue, C., Liu, X., & Xie, L. (2022) · Disease Markers · doi:10.1155/2022/9515571 · Cited by 10
“TGFβ (transforming growth factor-beta) belongs to a group of growth factors that are members of the TGF superfamily and are important in mediating various cellular functions [51].”
BackgroundRetractedRNF185 Control of COL3A1 Expression Limits Prostate Cancer Migration and Metastatic Potential
Espen, B. V., Oo, H. Z., Collins, C. C., Fazli, L., Molinolo, A., Yip, K. Y.-L., Murad, R., Gleave, M. E., & Ronai, Z. A. (2023) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-23-0512 · Cited by 10
Recent update on anti-tumor mechanisms of valproic acid in glioblastoma multiforme
Vatankhah, A., Moghaddam, S. H., Afshari, S., Afshari, A. R., Kesharwani, P., & Sahebkar, A. (2024) · Pathology - Research and Practice · doi:10.1016/j.prp.2024.155636 · Cited by 9
The immunoreactivity of TGF-b1 in non-alcoholic fatty liver disease
Kempiński, R., Neubauer, K., Poniewierka, E., Kaczorowski, M., & Hałoń, A. (2019) · Folia Histochemica et Cytobiologica · doi:10.5603/fhc.a2019.0008 · Cited by 9
Jia, H., Hao, S., Cao, M., Wang, L., Bai, H., Shui, W., & Yang, X. (2022) · Disease Markers · doi:10.1155/2022/8700372 · Cited by 9
“It is known that TGFbeta signaling and Wnt signaling can promote tumor immune evasion and metastasis and are potential antitumor therapeutic targets [34, 35].”
BackgroundLINC01146/F11R facilitates growth and metastasis of prostate cancer under the regulation of TGF-β
Guo, X., Gu, Y., Guo, C., Pei, L., & Hao, C. (2022) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2022.106193 · Cited by 9
Chen, G., Zhu, Y., Liang, X. H., Wang, X., Yu, W., Guo, J., Zhu, L., & Ma, R. (2020) · BioMed Research International · doi:10.1155/2020/8815904 · Cited by 9
“In addition to the promotion the process of a profibrogenic, TGF-β is also used as a strong promoter of cancer [6, 7].”
BackgroundTamura, A., Yamagata, K., Kono, T., Fujimoto, M., Fuchigami, T., Motoi, N., Yokoyama, M., Nakayama, A., Hashimoto, N., Sakuma, I., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-59886-w · Cited by 8
Vitamin C in the Management of Thyroid Cancer: A Highway to New Treatment?
Gorini, F., & Tonacci, A. (2024) · Antioxidants · doi:10.3390/antiox13101242 · Cited by 8
“…overexpressed in human cancers, including TC, able to modulate various processes, such as cell proliferation, differentiation, apoptosis, and migration and acting both as tumor suppressor in the premalignancy phase and as an invasion and metastasis promoter in the advanced stage of cancer [19,115].”
Sadri, S., Aghajani, A., Soleimani, H., Kalkhajeh, S. G., Nazari, H., Milan, P. B., Peyravian, N., Pezeshkian, Z., Kebria, M. M., Shirazi, F., et al. (2024) · Biochemical Genetics · doi:10.1007/s10528-024-10988-y · Cited by 8
“Cell motility and vascular growth are enhanced in mCRC tumor cells by TGF-β, which improves the production of Runt-Related Transcription Factor-1 (Hawinkels et al. 2009; Soleim-ani et al. 2019; Xie et al. 2018).”
Alabi, F. A., Okpalanwaka, I. F., Oyegbesan, A., Okoyeocha, E. O. M., Oladejo, M., & Imodoye, S. O. (2025) · MedComm – Oncology · doi:10.1002/mog2.70027 · Cited by 9
Xia, T., Lei, H., Wang, J., He, Y., Wang, H., Gao, L., Qi, T., Xiong, X., Liu, L., & Zhu, Y. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.1008053 · Cited by 8
“” As we all know, the transforming growth factor (TGF)-β signaling events are to control diverse processes and numerous responses, such as cell proliferation, differentiation, apoptosis, and migration (Xie et al., 2018).”
BackgroundSIRT7 and p53 interaction in embryonic development and tumorigenesis
Vázquez, B. N., Fernández-Duran, I., Hernandez, Y., Tarighi, S., Thackray, J. K., Espinosa‐Alcantud, M., Kumari, P., Ianni, A., Cesaire, L., Braun, T. W., et al. (2024) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1281730 · Cited by 8
Bryukhovetskiy, I., Шевченко, В. Е., Arnotskaya, N. E., Kushnir, T., Pak, O., Victor, Z., Zaitsev, S., Khotimchenko, Y. S., Bryukhovetskiy, A. S., Sharma, A., et al. (2020) · International review of neurobiology · doi:10.1016/bs.irn.2020.03.007 · Cited by 8
Kelch-like protein 14 promotes proliferation and migration of ovarian cancer cells.
Chen, Z., Wu, M., & Liu, J. (2020) · International Journal of Clinical and Experimental Pathology · Cited by 8
Permatasari, H. K., Bdira, S. B., Moon, M., Amalia, N., Sulistomo, H. W., Riawan, W., Choi, J., Chung, S., Park, M. N., Seo, B.-K., et al. (2023) · Journal of Agriculture and Food Research · doi:10.1016/j.jafr.2023.100796 · Cited by 8
Peng, R., Huang, Y., Huang, P., Liu, L., Cheng, L., & Peng, X. (2024) · Cancer Biomarkers · doi:10.3233/cbm-230354 · Cited by 7
“TGF-β can increase the expression of N-cadherin and vimentin and decrease the expression of E-cadherin by activating EMT transcription factors SNAIL, TWIST, and ZEB through down-stream Smad proteins, thus promoting the EMT process [56].”
BackgroundmiRNAs in oral cancer; diagnostic and prognostic roles
Arabi, K., Salman, B. N., Rahimzadeh‐Bajgiran, F., Moghbeli, M., Moghadas, S., & Saburi, E. (2025) · Gene · doi:10.1016/j.gene.2025.149382 · Cited by 7
Molecular signaling network and therapeutic developments in breast cancer brain metastasis
Benjamin, M., Malakar, P., Sinha, R. A., Nasser, M. W., Batra, S. K., Siddiqui, J. A., & Chakravarti, B. (2022) · Advances in Cancer Biology - Metastasis · doi:10.1016/j.adcanc.2022.100079 · Cited by 7
Isatin inhibits the invasion and metastasis of SH‑SY5Y neuroblastoma cells in vitro and in vivo
Hua, Y., Zhou, N., Zhang, J., Zhang, Z., Li, N., Wang, J., Zheng, W., Li, X., Wang, F., Zhang, L., et al. (2020) · International Journal of Oncology · doi:10.3892/ijo.2020.5144 · Cited by 7
Self-citationRole of Non-Coding RNAs in TGF-β Signalling in Glioma
Shree, B., & Sharma, V. (2023) · Brain Sciences · doi:10.3390/brainsci13101376 · Cited by 8
“In normal cells and the early stages of cancer, TGF-β restrains cell proliferation whereas, in advanced stages of cancer, due to accumulation of mutations in the TGF-β pathway components or selective impairment of its tumour-suppressive function, it turns out to be oncogenic [24–26].”
BackgroundLim, H., Yang, T., Lee, W., & Park, S. (2021) · Biomedicines · doi:10.3390/biomedicines9080896 · Cited by 7
“Many studies have shown the roles of TGF-β in tumor metastasis [24,25] and immune modulation.”
BackgroundMohiuddin, M., & Kasahara, K. (2021) · Journal of Infection and Public Health · doi:10.1016/j.jiph.2021.12.004 · Cited by 7
Evaluating TGF-β1 gene expression and promoter polymorphism in cervical cancer progression
Poleboyina, P. K., Pasha, A., Heena, S. K., Poleboyina, S. M., & Pawar, S. C. (2025) · Journal of Molecular Histology · doi:10.1007/s10735-025-10402-w · Cited by 6
“…plays a crucial role in several cellular processes, including modulating immunological responses, inhibiting tumor growth, differentiating cell types, facilitat - ing cellular movement, invading adjacent regions, and modifying the extracellular matrix (Xie et al. 2018; Poleboyina et al. 2024 ).”
Shi, D., Qin, Y., Liu, S., Zhao, R.-N., He, J., Ma, R., & Gao, P. (2026) · British Journal of Cancer · doi:10.1038/s41416-025-03326-5 · Cited by 6
Conlon, T., Schaaf, M., Mateos‐Maroto, A., Picciotto, S., Morsbach, S., Adamo, G., Si, S., Lieberwirth, I., Rosenauer, C., Landfester, K., et al. (2025) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.118081 · Cited by 6
Epithelial to Mesenchymal Transition
Dalton, A. C., & Howe, P. H. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820472-6.00005-0 · Cited by 6
Qiu, W., Zhang, S., Yu, W., Liu, J., & Wu, H. (2024) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2024.108867 · Cited by 6
Targeting the metastatic niche: Single-cell lineage tracing in prime time
Sommer, E. R., Napoli, G. C., Chau, C. H., Price, D. K., & Figg, W. D. (2023) · iScience · doi:10.1016/j.isci.2023.106174 · Cited by 7
“displayed peaks in TGF-b signaling, an inducer of EMT andmetastasis in the later phases of cancer progression.(37)Within a particularly aggressive clone, the s100a gene family, implicated in tumor growth andmetastasis for many cancer types,(38) was 52-fold overenriched among genes positively associated with subclonal…”
BackgroundBetaglycan Gene (TGFBR3) Polymorphism Is Associated with Increased Risk of Endometrial Cancer
Zakrzewski, P. K., Forma, E., Cygankiewicz, A. I., Bryś, M., Wójcik‐Krowiranda, K., Bieńkiewicz, A., Semczuk, A., & Krajewska, W. M. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9103082 · Cited by 6
“Moreover, in cancer cells, disturbed signal mediation in TGFβ pathway triggers its role from a tumor suppressor, early in neoplastic transformation, to a cancer-promoting and metastatic agent in advanced clinical stages of the disease [33].”
BackgroundIdris, M. K. H., Hasham, R., & Ismail, H. F. (2022) · DARU Journal of Pharmaceutical Sciences · doi:10.1007/s40199-021-00414-8 · Cited by 6
A special issue on TGF-β signaling: regulation, crosstalk, and biology
Yan, X., & Zhang, L. (2017) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmx134 · Cited by 6
Self-citationKim, C., Kim, S., Shin, R., Kim, M. J., Jeong, S., Park, J. W., & Ku, J. (2025) · Translational Oncology · doi:10.1016/j.tranon.2025.102592 · Cited by 5
“In xenograft model, tumor volume and hepatic metastases were reduced in the group treated with the TGF-β signaling inhibitor, leading to prolonged overall survival of mice [41,42].”
The role of TGF-β and antimicrobial peptides in basal cell carcinoma: a systematic review
Fijałkowska, M., Bonczar, M., Jastrzębski, I., Ostrowski, P., Antoszewski, B., & Koziej, M. (2023) · Advances in Dermatology and Allergology · doi:10.5114/ada.2023.124747 · Cited by 5
Ye, R., Zeng, H., Liu, Z., Jin, K., Liu, C., Yan, S. R., Yu, Y., You, R., Zhang, H., Chang, Y., et al. (2021) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-021-02987-4 · Cited by 5
Yang, Y., Lu, Y., Zhou, Y., Sun, H., Ma, Y., Tan, J., Li, N., & Li, H. (2023) · Avian Pathology · doi:10.1080/03079457.2023.2181146 · Cited by 5
“Abnormal TGF-beta responsiveness and its signalling pathway can cause many diseases in humans (Syed, 2016; Colak & Ten Dijke, 2017; Xie et al., 2018).”
Gao, M., Liao, L., Lin, Z., Hu, X., Jia, L., Gong, W., & Jia, X. (2024) · Translational Cancer Research · doi:10.21037/tcr-23-1766 · Cited by 4
TGF-β1-induced RAP2 regulates invasion in pancreatic cancer
Jin, K., Liu, C., Cheng, H., Fei, Q., Huang, Q., Xiao, Z., Yu, X., & Wu, W. (2022) · Acta Biochimica et Biophysica Sinica · doi:10.3724/abbs.2022015 · Cited by 4
Sonsomnuek, P., Tarasuk, M., Plengsuriyakarn, T., Boonprasert, K., & Na‐Bangchang, K. (2022) · Asian Pacific Journal of Cancer Prevention · doi:10.31557/apjcp.2022.23.9.3093 · Cited by 4
Feng, M., Sun, M.-J., Xu, B., Liu, M., Zhang, H., & Wu, C. (2023) · World Journal of Gastroenterology · doi:10.3748/wjg.v29.i24.3770 · Cited by 4
Wang, P., Zhuang, W., Zheng, Z., Zhang, L., Zhang, X., & Chen, Q. (2023) · Clinical & Experimental Immunology · doi:10.1093/cei/uxad073 · Cited by 4
Self-citationA systematic review of genes affecting mitochondrial processes in cancer
Sepúlveda-Villegas, M., Rojo, R., Garza-Hernandez, D., de la Rosa-Garza, M., & Treviño, V. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2020.165846 · Cited by 4
MicroRNA-185: A non-invasive diagnostic and prognostic tumor marker
Ghasaban, F. T., Akhlaghipour, I., Taghehchian, N., Maharati, A., Memar, B., & Moghbeli, M. (2023) · Process Biochemistry · doi:10.1016/j.procbio.2023.05.024 · Cited by 4
Ma, L., Sakamoto, Y., Kanai, A., Otsuka, H., Takahashi, A., Kakimi, K., Imai, T., & Shimokawa, T. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21082829 · Cited by 4
“Other reports revealed that the CD40/CD154 signaling pathway was a key factor for metastasis-related transforming growth factor-beta (TGF-beta) production in cancer cells [35,36] and also for matrix metalloproteinases secretion in aorta and podocytes [37,38].”
BackgroundRuders, J. H., Ahmad, S. M., Mortensen, R. E. J., Met, Ö., Byrdal, M., Chen, I. M., Theile, S., Holmström, M. O., & Andersen, M. H. (2026) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-026-02626-3 · Cited by 3
GDF10 exacerbates metastatic burden and cachexia in murine models of cancer
James, L. S., Saunders, A. A. E., Karagiannis, C., Qian, H., Anderson, R. L., Thomson, R. E., Goodman, C. A., & Gregorevic, P. (2026) · Frontiers in Physiology · doi:10.3389/fphys.2026.1773275 · Cited by 3
“Signaling via the Transforming Growth Factor-b (TGF-ß) network has been investigated in multiple disease pathologies (Xie et al., 2018; Tzavlaki and Moustakas, 2020), including in cancer.”
Acosta-Montaño, P., Félix, E. O., Flores, V. C., García, A. H., Cadena-Nava, R. D., Galindo‐Hernández, O., Juárez, P., & Fournier, P. G. J. (2024) · Biology · doi:10.3390/biology13121066 · Cited by 3
Yang, W., Cheng, R., Qin, M., Pan, X., Tan, Y., Feng, K., Zhang, J., & Huang, J. (2025) · Frontiers in Oncology · doi:10.3389/fonc.2025.1562976 · Cited by 3
“TGF b signaling functions primarily through SMAD pathway (38, 39).”
Wang, M., Yue, M., Zhao, X., He, X., Zhang, H., Jin, J., & Wang, H. (2023) · Technology and Health Care · doi:10.3233/thc-220645 · Cited by 3
LINC00941: a novel player involved in the progression of human cancers
Yan, Q., Su, X., Chen, Y., Wang, Z., Han, W., Xia, Q., Mao, Y., Si, J., Li, H., & Duan, S. (2023) · Human Cell · doi:10.1007/s13577-023-01002-5 · Cited by 3
“Trans-forming growth factor β (TGF-β) is a pleiotropic cytokine that modulates multiple cellular responses, influences the immune system and the tumor microenvironment, and promotes tumor cell invasion and metastasis [44, 45].”
Xiang, S., Wang, M., Li, Q., & Yang, Z. (2024) · Translational Cancer Research · doi:10.21037/tcr-23-2120 · Cited by 3
Metformin relieves bone cancer pain by reducing TGFβRI-TRPV1 signaling in rats
Zhou, F. J., Qian, H., Wang, K., Gu, Y.-J., Liu, P.-L., Zhang, L., Chen, L., Yu, S., Chen, Y., & Zhang, H. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e34991 · Cited by 3
“Excessive TGF β promotes tumor development, invasion, and metastasis in progressive bone cancer [39 – 41].”
BackgroundSelf-citationPotential of PAR-4 as a Therapeutic Target for Pancreatic Cancer
Uddin, M. H., Azmi, A. S., & Mohammad, R. M. (2021) · Springer eBooks · doi:10.1007/978-3-030-80558-6_10 · Cited by 3
ANALYSIS OF REGULATORY MOLECULES THAT MEDIATE METASTASIS AND ANGIOGENESIS IN HUMAN CANCER
(2018) · International Journal of Biology Pharmacy and Allied Sciences · doi:10.31032/ijbpas/2018/7.5.4449 · Cited by 3
Metadata
- Authors
- Xie, F., Ling, L., Van Dam, H., Zhou, F., & Zhang, L.
- Affiliations
- Soochow University (CN)
- Zhejiang University (CN)
- Venue
- Acta Biochimica et Biophysica Sinica
- Published
- 2018-01-01
- Volume
- 50
- Issue
- 1
- Pages
- 121-132
- ISSN
- 1672-9145 (ISSN-L)
- OpenAlex
- W2770010368
- Cited by
- 231
- References
- 125
- Citations by year
- 2026: 13 · 2025: 13 · 2024: 29 · 2023: 32 · 2022: 46 · 2021: 40 · 2020: 32 · 2019: 20 · 2018: 5
- FWCI
- 1.48
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Acta Biochimica et Biophysica Sinica (publishedVersion)
- PubMed (publishedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Leiden Repository (Leiden University) (submittedVersion)
- Funders
- The National Basic Research Program of China (2016YFA0502500)
- National Natural Science Foundation of China (31471315, 31671457, 31571460, 31701232)
- The National Science Foundation for Post-doctoral Scientists of China (BX201700165)
- Zhejiang Natural Science Foundation (R14C070002)
- Jiangsu Natural Science Foundation (BK20150354)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mechanisms of cancer metastasis
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Keywords
- TGF-beta signaling, metastasis, tumor suppressor function, tumor invasion, signaling crosstalk, Hippo signaling pathway, Wnt signaling, PI3K/Akt signaling, anti-TGF-beta therapy
- MeSH terms
- Antineoplastic Agents, Humans, Models, Biological, Neoplasm Metastasis, Neoplasms, Signal Transduction, Transforming Growth Factor beta, Disease Progression, Tumor Suppressor Proteins, Molecular Targeted Therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.